A
AristaMD
AristaMD - eConsult Solutions For Better Specialty Referrals
About AristaMD
AristaMD is a healthcare technology startup that aims to revolutionize primary care by providing a platform for electronic consultations (eConsults). The company operates in the healthcare market, specifically focusing on primary care providers and their patients. AristaMD's primary clients include primary care physicians (PCPs) and healthcare organizations looking to improve patient outcomes and reduce costs.
The AristaMD eConsult Platform allows primary care providers to consult with board-certified specialists in over 70 specialty areas. This service helps reduce unnecessary referrals to specialists, which can be costly and time-consuming. By leveraging eConsults, PCPs can get expert advice quickly, improving care coordination and patient satisfaction. This is particularly beneficial in managing chronic diseases and reducing emergency department (ED) visits and hospitalizations.
AristaMD's business model is based on a subscription service. Healthcare providers and organizations pay a fee to access the eConsult platform. This model ensures a steady revenue stream while providing significant value to its clients by reducing healthcare costs and improving patient outcomes.
The company makes money by charging healthcare providers for access to its platform. This fee is justified by the cost savings and improved patient care that result from using the service. For example, by reducing unnecessary specialist visits and hospital admissions, healthcare providers can save money and allocate resources more efficiently.
In summary, AristaMD is transforming primary care by providing a platform that connects primary care providers with specialists for electronic consultations. This service improves patient outcomes, reduces healthcare costs, and enhances the overall patient experience.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2014
- Headquarters
- San Diego, United States
- Employees
- 82
- Open positions
- 5
- Dealroom signal
- 87.8/100
- Industry
- Health
- Sub-industry
- Health Platform
- Sector
- Health Tech & Medtech, Risk Management, Predictive Analytics, Patient Care, Hard Tech, DT and LS, science-based
- Technology
- Deep Tech
- Client focus
- b2b
- Investment activity
- 2 companies, latest Nov 2023
- Capital deployed
- —
- Preferred round
- ACQUISITION
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES COther financing | Nov 2023 | $17M | $90M | Undisclosed | ↗ |
| LATE VCOther financing | Mar 2022 | $10M | $41M | CU Healthcare Innovation Fund | — |
Growth signals
Latest recorded traffic for AristaMD is 33K monthly website visits, up 240.2% over the last three months. AristaMD's team grew 24.2% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
SitkaSan Francisco, United StatesHospital & medical device company
$56Mvaluation
PreferralNashville, United StatesPreferral: Referral Management, Referral Analytics, and Online Referral Form Software
$92Kvaluation
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A8 investors entered at this stage
Avalon Ventures
Correlation Ventures
MemorialCare Innovation Fund
Cigna Ventures
CU Healthcare Innovation Fund
Stanford Health Care
.406 Ventures
Ascension
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about AristaMD on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See AristaMD’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







